Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
3.1 Basic medicine, Expert, Latvian Council of Science
18 Jun 2020 → 17 Jun 2023
3.1 Basic medicine, Expert, Latvian Council of Science
17 Aug 2017 → 16 Aug 2020
Field of Science
- 3.1 Basic medicine
Fingerprint
Dive into the research topics where Reinis Vilšķērsts is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Finished
-
Development of new anti-cancer medicines for treatment of rare tumours in triterpenoid group of lupane series
Vilšķērsts, R. & Turks, M.
15/02/16 → 28/02/19
Project: RSU grants
-
Data on cardiac and vascular functionality in ex vivo and in vivo models following acute administration of trimethylamine N-oxide
Videja, M., Vilskersts, R., Sevostjanovs, E., Liepinsh, E. & Dambrova, M., Feb 2023, In: Data in Brief. 46, 108890.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Meldonium Therapy Improves the Right Ventricle Function
Kigitovica, D., Korzh, S., Videja, M., Vilks, K., Makrecka-Kuka, M., Liepins, E., Skride, A., Dambrova, M. & Vilskersts, R., 2023.Research output: Contribution to conference › Poster
-
Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials
Dambrova, M., Makrecka-Kuka, M., Kuka, J., Vilskersts, R., Nordberg, D., Attwood, M. M., Smesny, S., Sen, Z. D., Guo, A. C., Oler, E., Tian, S., Zheng, J., Wishart, D. S., Liepinsh, E. & Schiöth, H. B., 1 Jul 2022, In: Pharmacological Reviews. 74, 3, p. 506-551 46 p.Research output: Contribution to journal › Review article › peer-review
Open AccessFile21 Citations (Scopus)6 Downloads (Pure) -
Cardioprotection by selective SGLT-2 inhibitors in a non-diabetic mouse model of myocardial ischemia/reperfusion injury: a class or a drug effect?
Nikolaou, P. E., Mylonas, N., Makridakis, M., Makrecka-Kuka, M., Iliou, A., Zerikiotis, S., Efentakis, P., Kampoukos, S., Kostomitsopoulos, N., Vilskersts, R., Ikonomidis, I., Lambadiari, V., Zuurbier, C. J., Latosinska, A., Vlahou, A., Dimitriadis, G., Iliodromitis, E. K. & Andreadou, I., Dec 2022, In: Basic Research in Cardiology. 117, 1, 27.Research output: Contribution to journal › Article › peer-review
9 Citations (Scopus) -
Protective effects of meldonium in experimental models of cardiovascular complications with a potential application in COVID‐19
Vilskersts, R., Kigitovica, D., Korzh, S., Videja, M., Vilks, K., Cirule, H., Skride, A., Makrecka‐Kuka, M., Liepinsh, E. & Dambrova, M., 1 Jan 2022, In: International Journal of Molecular Sciences. 23, 1, 45.Research output: Contribution to journal › Article › peer-review
Open AccessFile2 Citations (Scopus)50 Downloads (Pure)
Activities
- 1 Oral presentation
-
Targeting mitochondrial bioenergetics as a therapeutic strategy for cardiopulmonary complications related to COVID-19
Reinis Vilšķērsts (Speaker)
24 Mar 2021Activity: Talk or presentation types › Oral presentation
Press/Media
-
Studies from Latvian Institute of Organic Synthesis Have Provided New Data on Science and Technology (Data on cardiac and vascular functionality in ex vivo and in vivo models following acute administration of trimethylamine N-oxide)
Melita Vidējā & Reinis Vilšķērsts
3/02/23
1 item of Media coverage
Press/Media